Wed, 03 Mar 2010 07:51:23 GMT
Ranbaxy Falls After U.S. FDA Rejects Application to Sell Drug (Bloomberg)
March 3 (Bloomberg) -- Ranbaxy Laboratories Ltd. fell as much as 6.4 percent after the U.S. Food and Drug Administration rejected the Indian drugmaker’s application for selling the generic version of Flomax to treat enlarged prostate glands. | Wed, 03 Mar 2010 02:21:14 GMT
Daiichi Sankyo Says FDA Rejected Ranbaxy’s Generic Flomax (Bloomberg)
March 3 (Bloomberg) -- Daiichi Sankyo Co., which controls 64 percent of Ranbaxy Laboratories Ltd., said the U.S. Food and Drug Administration rejected its Indian unit’s application for approval to sell the generic version of Flomax to treat enlarged prostate glands. | Tue, 09 Mar 2010 17:13:00 GMT
Reportlinker Adds Global Anti-Hypertensive Drugs Industry (PR Newswire via Yahoo! Finance)
Reportlinker.com announces that a new market research report is available in its catalogue: | Sun, 07 Mar 2010 09:27:44 GMT
Court briefs (The News Journal)
AstraZeneca Plc has sued India's Sun Pharmaceuticals Industries Ltd. to prevent it from selling a generic form of the ulcer medicine Nexium IV in the U.S. before 2014. Sun is seeking U.S. | Fri, 26 Feb 2010 05:22:38 GMT
Ranbaxy Shares Fall on Earnings Forecast, FDA Issues (Update1) (Bloomberg)
Feb. 26 (Bloomberg) -- Ranbaxy Laboratories Ltd. dropped the most in nine months in Mumbai trading after forecasting 2010 profit that missed analysts’ expectations. | Fri, 26 Feb 2010 10:06:25 GMT
Daiichi Sankyo & Ranbaxy announce establishment of Daiichi Sankyo Espha to market generic drugs (PharmaBiz)
Daiichi Sankyo Company Limited and Ranbaxy Laboratories Limited announced that Daiichi Sankyo will establish Daiichi Sankyo Espha Co, Ltd (Daiichi Sankyo Espha) on April 1, 2010. | Thu, 25 Feb 2010 14:21:22 GMT
Ranbaxy Forecasts Profit Gain in 2010 on Valtrex Copy (Update1) (Bloomberg)
Feb. 25 (Bloomberg) -- Ranbaxy Laboratories Ltd. , India’s largest drugmaker, forecast profit will increase 48 percent in 2010 helped by U.S. sales of a generic copy of GlaxoSmithKline Plc’s genital herpes treatment. |
|
|
|
Wed, 03 Mar 2010 08:05:54 GMT+00:00
| Thu, 25 Feb 2010 13:57:44 GMT+00:00
| Thu, 25 Feb 2010 23:07:44 GMT+00:00
| Thu, 04 Mar 2010 04:32:57 GMT+00:00
|
Corporate WatchWall Street JournalContinental's flights on its regional partners also will offer roomier seats for sale, although the number will be limited. Ranbaxy Laboratories Ltd. said ...and more » |
| Thu, 25 Feb 2010 13:50:13 GMT+00:00
| Tue, 09 Mar 2010 17:01:28 GMT+00:00
| Tue, 09 Mar 2010 12:17:59 GMT+00:00
|
|
|
